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ABSTRACT
Pharmacokinetic and pharmacodynamic (PK/PD)-models describe and predict the
time course of drug eﬀects resulting from a certain dosage administered to an organ-
ism. PK/PD models beneﬁt all phases of preclinical and clinical drug development.
Their wider application in clinical therapy is to determine the speciﬁc dosage for a
patient. In this thesis, we review several PK/PD models and investigate the time-to-
peak, T , of the models. We state and prove a theorem about the uniqueness of T .
The theorem considers PK/PD modes which are linear and nonlinear in the response
variable. We show that if the forcing function and the response function satisfy some
conditions, then there exists only one peak in the response variable. We apply this
theorem to several PK/PD models which have a unique T and show that the con-
dition of the theorem were satisﬁed. The theorem is also used to investigate how T
changes with respect to drug dosage D for the turnover models considered.
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Chapter 1
Introduction
The health of living organisms changes frequently due to environmental, genetic,
dietary and various other reasons. These changes trigger responses from the organism
such as growth factors, concentration of hormones or any other biological responses.
The administration of drugs to living organisms has become an important part in
assisting living organisms to produce the necessary responses to the changes in its
environment. There are two diﬀerent reactions which occur between an organism and
the concentration of drug which are deﬁned in the next section.
The analysis throughout this paper focuses on administration of drugs into the blood
stream of an organism, however, it is valid for any application governed by a ﬁrst order
ordinary diﬀerential equation with diminishing forcing and other mild restriction on
the form of the feedback.
1.1 Motivation for PK/PD Models
The eﬀective use of drugs has been advanced by better understanding of the relation-
ship between the administered dose and the resulting biological responses or phar-
macological eﬀects ; Krzyzanski (2000). The ability to produce a required response
of an administered drug is determined by its pharmacokinetic or pharmacodynamic
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properties.
Pharmacokinetics describes the time course of the concentration of a drug in a
body ﬂuid, either in the plasma or blood, that results from a given dosage of a drug.
This is basically, how the body responds to a drug.
Pharmacodynamics also describes the intensity of a drug eﬀect in relation to its
concentration in the ﬂuid. In simple words, what the drug does to the body ; Meibohm
and Derendorf (1997).
So PK/PD models incorporate these two processes and tries to determine the eﬀects
resulting from a drug administration over some time period.
1.2 PK/PD Models
We discuss several theoretical PK/PD models by Meibohm and Derendorf (1997),
Krzyzanski and Jusko (1998), Peletier et al. (2005) and Nguyen et al. (2009). These
are called the turnover models, and are discussed in chapter 2.
We also investigate other models by Theis et al. (2011) which use a simple reaction
model A → B that is regulated by a transient input that deactivates B over time by
degradation. This simple reaction is modiﬁed and extended to include other back-
reactions, and is discussed in chapter 2.
1.2.1 PK/PD Models and Time to Peak
Some speciﬁc outcomes have been associated with the maximal amplitude of a re-
sponse and the time (time-to-peak) for such a peak response, and there are many
studies which investigate this phenomenon. For example, Theis et al. (2011), Nguyen
et al. (2009) and Gabrielsson and Peletier (2014) have obtained some results in this
respect.
In chapter 2, we introduce and investigate several models by Theis giving some details
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of their solutions. We also discuss the dimensionless version of the turnover models
referenced in Nguyen et al. (2009) and ﬁnd the general solution to the models.
In chapter 3, we state and prove a theorem which shows the existence of only one
maximum amplitude (time-to-peak) for a general PK/PD model under some required
conditions.
Analysis on time-to-peak is discussed in chapter 4 where the dependence of time-to-
peak on the drug dosage is investigated using a general linear PK/PD model.
3
Chapter 2
Review of Selected Models
PK/PD models have been discussed by many researchers. The models discussed here
are typical PK/PD models with some variations. We will explain and review 3 of
the models stated by Theis et al. (2011) with results leading to our model which
is discussed in the following chapters. We will also formalize some of the results
discussed by Khavari (2011).
2.1 PK/PD Models by Theis
The six models discussed here are sometimes called reaction models, which will be
referred as RM-1 through RM-6. These models as proposed by Theis et al. (2011)
are ﬁrst order ordinary diﬀerential equations describing how the response of a system
changes with time, when a drug has been administered into the system of an organism.
We let R(t) be the time dependent variable representing the response of a system.
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2.1.1 RM-1
RM-1 is the ﬁrst order initial value problem,
dR(t)
dt
= af(t)− kR(t)
R(0) = 0. (2.1.1)
In this model, rate of change of the response R(t) depends on a forcing f(t) and the
parameter a, considered as the drug dosage, which is a constant in this model. So
af(t) is the rate at which the concentration of drug varies with time in the system.
We will require that f(t) diminishes as time elapses. This requirement is also realistic
since one will expect the concentration of a drug in a system to diminish with time.
The change in response at any time also depends on the response of the organism.
This phenomenon is explained by the term kR(t) where the negative sign indicates a
reduction in R(t) for positive rate constant k. The initial condition assumes there is
no response until the drug is administered to the body.
We can ﬁnd the general solution for this model by using an integrating factor
μ(t) = e
∫ t
t0
kdτ
= ek(t−t0). (2.1.2)
The diﬀerential equation (2.1.1) becomes
d
dt
(R(t)μ(t)) = aμ(t)f(t), (2.1.3)
which can be integrated both sides from t0 to t, giving
R(t) =
1
μ(t)
(
R(t0) + a
∫ t
t0
f(τ)μ(τ)dτ
)
. (2.1.4)
Theis discusses two cases for the switching function, f(t), a discrete and continuous
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form. For the discrete case, Theis lets f(t) =
⎧⎪⎨
⎪⎩
1 for t < 1
0 for t ≥ 1.
For t < 1
together with the initial condition t0 = 0, R(0) = 0 we have
R(t) =
a
k
(1− e−kt) for 0 ≤ t < 1. (2.1.5)
From (2.1.5) we get R(1) = a
k
(
1− e−k). Since R is assumed to be continuous function
for all t, it is deﬁned at t = 1. For t ≥ 1, we take t0 = 1 and μ(t) = ekt−k. Using the
above solution, (2.1.4) gives that
R(t) = R(1)ek(1−t) (2.1.6)
and R(t) =
a
k
(
e−k(t−1) − e−kt) for t ≥ 1. (2.1.7)
Thus R(t) =
⎧⎪⎨
⎪⎩
a
k
(1− e−kt) for 0 ≤ t < 1
a
k
(e−k(t−1) − e−kt) for t ≥ 1.
(2.1.8)
Figure 2.1 shows a plot of the solution using a = 0.5 and k = 3.
Figure 2.1: Discrete case of RM-1 for a = 1 and k = 1
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For the continuous case, Theis let f(t) = 1
1+t
. Using the general equation in (2.1.4)
we get that
R(t) =
a
ekt
(∫ t
0
ekτ
1 + τ
dτ
)
. (2.1.9)
Making a substitution for u = k(1 + τ) we have
R(t) = ae−k(t+1)
(∫ k(t+1)
k
eu
u
du
)
. (2.1.10)
The Exponential Integral is deﬁned as Ei(x) =
∫ x
−∞
ey
y
dy and hence the explicit
solution can be written as
R(t) = ae−k(t+1)[Ei(kt+ k)− Ei(k)]. (2.1.11)
Figure 2.2 shows a plot of the solution using a = 1 and k = 1.
Figure 2.2: Continuous case of RM-1 for a = 1 and k = 1
Both solutions of RM-1, (2.1.8) and (2.1.11), explains that the response variable
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diminishes as time becomes large. This result corresponds to the realistic situation
when the concentration of a drug diminishes.
2.1.2 RM-2
This model is a system of 2 ﬁrst order linear diﬀerential equations, given by
dA(t)
dt
= −A(t)f(t) (2.1.12)
dR(t)
dt
= A(t)f(t)− kR(t) (2.1.13)
with initial condition A(0) = 0 (2.1.14)
R(0) = 0 (2.1.15)
In this model, the drug function is denoted A(t) and R(t) is the drug response variable.
The drug concentration, A(t)f(t), allows the dosage to change with respect to time.
Using the continuous function f(t) = 1
1+t
we can solve for A(t) and substitute it into
the equation for R(t). Solving for A(t) we have that,
∫ t
0
dA(t)
A(t)
= −
∫ t
0
1
1 + τ
dτ. (2.1.16)
By substituting u = (1 + τ) and integrating, we then have
ln
A(t)
A(0)
= − ln(1 + t) + ln(1) (2.1.17)
and
A(t) =
a
1 + t
. (2.1.18)
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Substituting this result into the diﬀerential equation for R(t) we have the ﬁrst order
diﬀerential equation
dR(t)
dt
=
a
(1 + t)2
− kR(t) (2.1.19)
This equation is of the form (2.1.1) with same integrating factor as (2.1.2). Using the
derived solution in (2.1.4) we have that
R(t) = ae−kt
∫ t
0
eks
(1 + s)2
ds. (2.1.20)
By the method of integration by parts we let u = eks and dv = 1
(1+s)2
ds and have
R(t) = ae−kt
[ −ekt
(1 + t)2
+ 1 + k
∫ t
0
eks
1 + s
ds
]
. (2.1.21)
Using the substitution τ = k(1+ s) and the deﬁnition of the exponential integral, we
get
R(t) = a
[
e−kt − 1
1 + t
+
k
ek(1+t)
[Ei(k(1 + t))− Ei(k)]
]
. (2.1.22)
Figure 2.3 shows a plot of the solution using a = 1 and k = 1.
The result of this model also suggests that as time goes to inﬁnity, the response
diminishes. This is a result one will expect in a real situation since after a drug has
been used by an organism, the response of the organism to the drug has to diminish
over time.
2.1.3 RM-3
The RM-3 model suggests a case where the drug function A(t) is regulated depending
on the response R(t). In this case, the changes in drug dosage(increase or decrease in
9
Figure 2.3: Solution for RM-2 using a = 1 and k = 1
dosage) depends on how the body’s response is, at a point in time. In other words, a
drug dosage is increased or decreased if the body’s response is eﬀective or not. Model
RM-3 is described as follows;
dA(t)
dt
= kR(t)− A(t)f(t) (2.1.23)
dR(t)
dt
= A(t)f(t)− kR(t), (2.1.24)
with the initial conditions A(t) = a (2.1.25)
R(0) = 0. (2.1.26)
For this system, note that
dA(t)
dt
+
dR(t)
dt
= 0, (2.1.27)
which implies that A(t) +R(t) = Q (2.1.28)
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where Q is a constant. Using the initial conditions we have, Q = a and thus
A(t) = a−R(t). (2.1.29)
Substituting this result into (2.1.24) we have
dR(t)
dt
= af(t)− (f(t) + k)R(t). (2.1.30)
Using f(t) = 1
1+t
we can solve this linear equation by ﬁnding the integrating factor
μ = e
∫ t
0(
1
1+t
+k)dt = (1 + t)ekt (2.1.31)
and R(t) =
a(1− e−kt)
k(1 + t)
. (2.1.32)
Substituting this result in (2.1.29) we have
A(t) = a+
a(e−kt − 1)
k(1 + t)
. (2.1.33)
Figure 2.4 shows a plot of the solution using a = 1 and k = 1.
The solution of RM-3 also diminishes as time goes to inﬁnity. In addition to the
above models, the following three models are also given by Theis et al. (2011) but we
give no closed form solution.
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Figure 2.4: Solution of RM-3 using a = 1 and k = 1
2.1.4 RM-4, RM-5 and RM-6
RM-4 considers the case where the rate of proportion for R(t) can be regulated from
two diﬀerent parameters k and q. It is a linear system given by;
dA(t)
dt
= kR(t)− A(t)f(t)
dR(t)
dt
= A(t)f(t)− (k + q)R(t)
RM-5 modiﬁes the rate of proportion of the response variable by using the current
response R(t) with q. RM-5 is a nonlinear model given by
dA(t)
dt
= kR(t)− A(t)f(t)
dR(t)
dt
= A(t)f(t)− (k + q ·R(t))R(t)
12
RM-6 is a variation of RM-5 given by
dA(t)
dt
= kR(t)− A(t)f(t)
dR(t)
dt
= A(t)f(t)− (k ·R(t) + q)R(t).
In the next section, we review, four PK/PD models which have received considerable
analysis by others.
2.2 Turnover Models
The turnover models (TM) and are divided into two groups; inhibiting models
(TM-1,TM-2) and stimulating models (TM-3, TM-4). Original Models are
given by Krzyzanski and Jusko (1998) and Sharma and Jusko (1996). However, we
use the non-dimensionalized versions found in Nguyen et al. (2009).
2.2.1 Inhibiting and Stimulating Models
All the turnover models have this general equation.
d r(t)
dt
= F (t)−H(t)r(t) (2.2.1)
and r(0) = 1 (2.2.2)
Similar to the reactions models, r(t) is the response variable, F (t) is the gain term
and H(t)r(t) is the loss term. We deﬁne the function φ(t,D) which is used frequently
as;
φ(t,D) =
De−t
1 +De−t
=
D
D + et
(2.2.3)
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whereD is a parameter indicating the magnitude of the initial drug dosage. So φ(t,D)
models the concentration of drug dosage. The ﬁrst and second model describes inhi-
bition and has the following deﬁnition for F and H;
TM-1 F (t) = k (1− αφ(t,D)), H(t) = k
TM-2 F (t) = k, H(t) = k (1− αφ(t,D))
The third and fourth models describe stimulation;
TM-3 F (t) = k (1 + αφ(t,D)) , H(t) = k
TM-4 F (t) = k, H(t) = k (1 + αφ(t,D))
Now, note that if D = 0, the gain term (indicated by arrow in left part of Figure 2.5)
is k and the loss term (right part of Figure 2.5) is kR.
So when some dosage of drug is administered initially, TM-1 uses the concentration
φ(t,D) to reduce the proportion of gain or input k (Figure 2.5) which in turn aﬀects
how R changes. TM-2 also uses φ(t,D) to reduce the proportion of loss (output) which
also aﬀects how R changes. Hence TM-1 and TM-2 are called Inhibiting Models.
In a similar approach, TM-3 and TM-4 increase the proportion of the gain and loss
respectively. Hence TM-3 and TM-4 are called Stimulating Models.
Figure 2.5: Illustration of the four turnover models
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In all cases, k is a positive constant and α is a constant in the range, (0, 1].
We must make a substitution to shift the initial response value to 0. This substitution
is not only convenient for analysis but requires modiﬁcation of the loss and gain terms.
Its signiﬁcance will be discussed later in chapter 3 after proving The Peak Theorem.
In TM-1, we make the substitution r(t) = 1− αR(t). So for t = 0,
r(0) = 1− αR(0)
which implies that for t = 0, R(0) = 0.
Now, d r(t)
dt
= −αdR(t)
dt
, so using the above substitution,
−αdR(t)
dt
= F (t)−H(t)(1− αR(t))
which implies that
dR(t)
dt
=
1
α
[H(t)− F (t)]−H(t)R(t).
Substituting the values of F and H for RM-1 above, we have
dR(t)
dt
=
1
α
[k − k(1− αφ)]− kR(t)
which then gives us
dR(t)
dt
= kφ(t,D)− kR(t)
For TM-1, the IVP we will later discuss is
dR(t)
dt
= f(t)− h(t)R(t)
R(0) = 0 (2.2.4)
where f(t) = kφ(t,D) and h(t) = k.
ForTM-2, we make the substitution r(t) = 1+αR(t). SoR(0) = 0 and d r(t)
dt
= αdR(t)
dt
.
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Making the appropriate substitution, we get
α
dR(t)
dt
= F (t)−H(t)(1 + αR(t))
which implies that
dR(t)
dt
=
1
α
[F (t)−H(t)]−H(t)R(t).
and
dR(t)
dt
=
1
α
[k − k(1− αφ(t,D))]− k(1− αφ(t,D))R(t)
which then gives us
dR(t)
dt
= kφ(t,D)− k(1− αφ(t,D))R(t)
Hence the IVP for TM-2 is
dR(t)
dt
= f(t)− h(t)R(t)
with R(0) = 0 (2.2.5)
where f(t) = kφ(t,D) and h(t) = k(1− αφ(t,D)).
In TM-3, we will let R(t) = 1 + r(t) and have R(0) = 0 and d r(t)
dt
= dR(t)
dt
. With the
appropriate substitution we have
α
dR(t)
dt
= F (t)−H(t)(1 +R(t))
which implies that
dR(t)
dt
=
1
α
[k(1 + αφ(t,D))− k]− kR(t)
which then gives us
dR(t)
dt
= kφ(t,D)− kR(t)
Hence the IVP for TM-3 is
dR(t)
dt
= f(t)− h(t)R(t)
with R(0) = 0 (2.2.6)
where f(t) = kφ(t,D) and h(t) = k.
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Likewise, making a substitution for r(t) = 1−R(t), the IVP for TM-4 becomes
dR(t)
dt
= f(t)− h(t)R(t)
with R(0) = 0 (2.2.7)
where f(t) = kφ(t,D) and h(t) = k(1 + αφ(t,D)). Note that TM-1 and TM-3 are
equivalent in the transformed variables.
2.2.2 General Solution of the Turnover Models
The general solution for the turnover models is
R(t) = e−
∫ t
0 h(τ)dτ
[∫ t
0
(
f(τ)e
∫ τ
0 h(s)ds
)
dτ
]
We will attempt to ﬁnd the explicit solution of each of the 4 models by writing them
in an integral form.
• General Solution for TM-1 and TM-3
TM-1 and TM-3 have the same equation under the new substitution hence same
general solution.
R(t) = e−
∫ t
0 kdτ
[∫ t
0
(
kφ(τ,D)e
∫ τ
0 kds
)
dτ
]
which then gives us R(t) = ke−kt
∫ t
0
φ(τ,D)ekτdτ
Figure 2.6 shows a plot of the solution using α = 0.5, k = 1 and D = 1.
• General Solution for TM-2
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Figure 2.6: Solution of TM-1 and TM-3 using α = 0.5, k = 1, D = 1
In a similar way, the general solution of (2.2.5) is given as
R(t) = e−
∫ t
0 k(1−αφ(τ,D))dτ
[∫ t
0
kφ(τ,D)e
∫ τ
0 k(1−αφ(τ,D))dsdτ
]
and R(t) = ke−kt+αk
∫ t
0 φ(τ,D)dτ
[∫ t
0
φ(τ,D)ekτ−αk
∫ τ
0 φ(s,D)dsdτ
]
(2.2.8)
Figure 2.7 shows a plot of the solution using α = 0.5, k = 1 and D = 1.
• General solution for TM-4
By change of sign, the general solution of TM-4 follows from TM-2.
R(t) = ke−kt−αk
∫ t
0 φ(τ,D)dτ
[∫ t
0
φ(τ,D)ekτ+αk
∫ τ
0 φ(s,D)dsdτ
]
(2.2.9)
Figure 2.8 shows a plot of the solution using α = 0.5, k = 1 and D = 1.
Finding an explicit solution to PK/PD models is diﬃcult and in most cases impossible
to ﬁnd in closed-form.
18
Figure 2.7: Solution of TM-2 using α = 0.5, k = 1, D = 1
Figure 2.8: Solution of TM-4 using α = 0.5, k = 1, D = 1
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Nonetheless, there are other ways to ﬁnd the properties of R without ﬁnding its
explicit solution. In chapter 3, we will show the dynamics of the response R(t) as
time changes. We will also show the existence of a time T where maximum response
occurs.
20
Chapter 3
The Time to Peak
The response variable R is maximum or minimum when dR(t)
dt
= 0. The time t = T
at which this maximum or minimum occurs is of interest since it is the time when a
drug concentration is at its highest or lowest value.
We will determine if there is more than one value of T where R takes on an extreme
value in any PK/PD model. We will also explore the dependence of T on drug dosage
D.
For all the models discussed, T is implicitly deﬁned so it is diﬃcult to analyze. In
this chapter, we state and prove the Peak Theorem which gives a general result on
the time to peak, T .
3.1 The Peak Theorem (Theorem P)
This insight and understanding of the Peak Theorem is due to Dr. David Pollack
of Youngstown State University. Theorem P was ﬁrst stated and proved by Pollack
and Khavari (2011). In this section, we provide details and a concise proof of the
theorem.
The focus of this analysis is to provide results on T which is explicitly deﬁned for all
the models discussed in chapter 2 and for any other model which satisfy the hypothesis
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of theorem P.
Consider the following IVP
d r(t)
dt
= c(t)[g(t)− p(r)] (3.1.1)
r(0) = 0 (3.1.2)
where c(t) is a diﬀerentiable function with 0 < b1 < c(t) < b2 and g(t) is a positive,
diﬀerentiable and diminishing function. That is, g(t) > 0, g′(t) < 0 and lim
t→∞
g(t) = 0.
The function p(r) is continuously diﬀerentiable in r and is strictly increasing with
p(0) = 0 and lim
r→∞
p(r) > g(0).
3.1.1 Theorem P (Peak Theorem). Let R(t) be a solution of the above IVP then
1. R(t) is deﬁned for t ≥ 0 on [0,∞).
2. R(t) is bounded; i.e. ∃ M such that 0 ≤ R(t) < M where 0 < M < ∞.
3. R(t) has a unique maximum; i.e. ∃ a time T1 > 0 such that R(t) is strictly
increasing on [0, T1] and strictly decreasing on [T1,∞)
4. Response diminishes to zero i.e. lim
t→∞
R(t) = 0.
To prove this theorem, we ﬁrst review the proof of the Intermediate Value Theorem
with a slight notiﬁcation.
3.1.2 Theorem (Intermediate Value Theorem-Modiﬁed-[IVTM]). Let f : [a, b] →
R be a continuous function such that f(a) > 0 and f(b) ≤ 0. Then ∃ κ ∈ (a, b] such
that f(κ) = 0 and f(x) > 0 for a ≤ x < κ.
Proof. Deﬁne N = {x ∈ [a, b]| f(x) ≤ 0} and let κ = inf(N). We want to show that
f(κ) = 0.
Suppose that f(κ) > 0, then κ 	∈ N since f(x) ≤ 0 for all x ∈ N . This is a
contradiction. Hence f(κ) ≤ 0.
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Now suppose that f(κ) < 0. By continuity let  > 0 then ∃ δ > 0 such that
|f(x)− f(κ)| <  whenever |x− κ| < δ. Let f(κ) = − then
− < f(x)− f(κ) < 
and 2f(κ) < f(x) < 0 ∀ x ∈ (κ− δ, κ+ δ).
This is a contradiction to the assumption that κ = inf(N) since f(x) < 0 for x ∈
(κ− δ, κ). Hence f(κ) ≥ 0.
This shows that f(κ) = 0 since f(κ) ≤ 0 and f(κ) ≥ 0.
3.1.3 Lemma. Given that f(κ) = 0 and f(x) > 0 for all a ≤ x < κ, then f ′(κ) ≤ 0.
Proof. By deﬁnition
f ′(κ) = lim
x→κ−
f(x)− f(κ)
x− κ
= lim
x→κ−
− f(x)
κ− x
and since − f(x)
κ− x < 0, f
′(κ) ≤ 0. (3.1.3)
Thus, the proof.
Next, we prove theorem P. The proof will be done in sections using IVTM and Lemma
3.1.3.
Let R(t) be a solution of the IVP for theorem P.
I From the IVP, c(t), g(t) and p(r) are continuous and p(r)] is continuously dif-
ferentiable. By the existence and uniqueness theorem of initial value problems
Teschl (2012), the solution, R(t), exists and is unique. Hence, R(t) is deﬁned.
II We now show that R′(0) > 0 and R(t) > 0 ∀ t ∈ (0,∞).
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Proof. If R(t) is a solution of the IVP (3.1.1), then
dR(0)
dt
= c(0)[g(0)− p(R(0))]
= c(0)[g(0)− p(0)]
= c(0)g(0)
> 0 since c(0) > 0, and g(0) > 0.
Having showed that R′(0) > 0, we now prove that R(t) > 0 ∀ t > 0. Note that
R′(t) is continuous since from the IVP c(t), g(t) and p(R(t)) are continuous. So
by deﬁnition, ∀  > 0, ∃ δ > 0, we have |R′(t)−R′(0)| <  whenever 0 < t < δ.
Let  = R′(0) since R′(0) > 0, then
|R′(t)−R′(0)| < R′(0)
0 < R′(t) < 2R′(0) ∀ t ∈ (0, δ).
Using the fact thatR(t) is continuous and diﬀerentiable in the interval 0 < t < δ,
by the Mean Value Theorem
R(t)−R(0)
t− 0 = R
′(τ), for some 0 < τ < δ.
This gives, R(t) = tR′(τ) > 0
Now, using the fact that R(t) > 0 ∀ t ∈ (0, δ) we now prove that R(t) > 0 for
all t ∈ [0,∞).
Suppose R(t) 	> 0 for all t ∈ [0,∞) then R(t) ≤ 0 for some t ∈ [0,∞]. Let
a ∈ (0, δ) and δ < b < ∞ with R(b) ≤ 0. By the IVTM and lemma 3.1.3
∃ κ ∈ [a, b] such that R(κ) = 0, R′(κ) ≤ 0 and R(t) > 0 for a < t < κ.
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Calculating R′(κ),
R′(κ) = c(κ)[g(κ)− p(R(κ))]
= c(κ)g(κ) > 0
which is a contradiction to IVTM and the lemma that R′(κ) ≤ 0. Hence
assumption is false and so R(t) > 0 for all t ∈ (0,∞).
III We show that R(t) is bounded above, i.e. there exists an M > 0, such that
R(t) < M for all t ∈ [0,∞). We deﬁne M > 0 such that p(M) = g(0).
Proof. Let Φ(t) = M − R(t) then Φ(0) = M > 0. To show that R(t) < M
∀ t ∈ [0,∞) we must show that Φ(t) > 0, ∀ t ∈ [0,∞).
Assuming the contrary, then R(t) ≥ M which implies Φ(b) ≤ 0 for some b ∈
(0,∞).
Now, by the IVTM, let a = 0 which means Φ(a) > 0 and 0 < b < ∞, then
∃ κ ∈ (a, b] such that Φ(κ) = 0, Φ(t) > 0 for 0 < t < κ and Φ′(κ) ≤ 0.
Notice that Φ′(t) = −R′(t) and for Φ(κ) = 0 we have R(κ) = M . So the IVP
(3.1.1) at t = κ gives
Φ′(κ) = −{c(κ)[g(κ)− p(R(κ))]}
= −c(κ)[g(κ)− p(M)].
From our deﬁnition p(M) = g(0) which implies that
Φ′(κ) = c(κ)(g(0)− g(κ)).
Since g(0)− g(κ) > 0 and c(κ) > 0, we have Φ′(κ) > 0. This is a contradiction,
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so R(t) < M for all t ∈ [0,∞).
Since 0 < R(t) < M for all t in the domain of deﬁnition of R, it implies that the
solution exists on [0,∞) The next two proofs show that R(t) increases initially
to reach a maximum and then decreases to zero afterwards. Deﬁne the regions
A1 = {(t, r)|g(t)− p(r) > 0}
A2 = {(t, r)|g(t)− p(r) = 0}
and A3 = {(t, r)|g(t)− p(r) < 0}.
Note that, these are the only regions where the solution R(t) exists or is deﬁned.
IV We show that R(t) is strictly increasing in the region A1 and leaves this region
at some time.
Proof. Given that g(t) − p(r) > 0 is in A1 and c(t) > 0, the solution R(t) is
always increasing in A1 since R
′(t) > 0 in that region.
Now assume that the solution stays in A1 for all times, that is g(t) > p(R(t))
for all times. Choose t0 > 0 so that R(t0) > 0 then since R(t) is increasing
whenever t > t0, R(t) > R(t0) in A1.
Also, p(r) is strictly increasing and so p(R(t)) > p(R(t0)). Hence, by our
assumption g(t) > p(R(t)) > p(R(t0)) for all times t > t0.
This is a contradiction since lim
t→∞
g(t) = 0.
From I, II and III, we have shown that the solution R(t) is increasing in A1
and bounded above by some number M .
Since R(t) cannot stay in A1 at all times, there exists a time T where it leaves
A1; meaning when g(t)− p(R(t)) ≤ 0. But g(t)− p(R(t)) = 0 is when R′(t) = 0
26
and so region A2 corresponds to the time T when the response R(t) is at its
maximum.
In the next proof we show that there is only one such T and whenever t > T , the
solution is decreasing i.e. R′(t) < 0 and stays in the region A3, never returning
to A1 or A2.
V Let T > 0 be the ﬁrst time R(t) is in A2. We show that for all t > T , R(t) ∈ A3.
In other words, if T is the ﬁrst time R(t) is in A2 then for t > T , R
′(t) < 0.
Proof. Assume the contrary. Then ∃ t > T such that R′(t) ≥ 0.
Let t1 be the ﬁrst time after T when R
′(t) = 0. So R′(T ) = R′(t1) = 0 where
T < t1 < ∞, and R′(t) < 0 for T < t < t1. By diﬀerentiability of R′(t),
R′′(t1) = lim
t→t−1
R′(t)−R′(t1)
t− t1
= lim
t→t−1
R′(t)
t− t1
≥0 for R′(t) < 0 and t− t1 < 0. (3.1.4)
However, taking the derivative of r′(t) in (3.1.1) at t1, R′′(t1), we have
R′′(t1) = c′(t1)[g(t1)− p(R(t1))] + c(t1)[g′(t1)− p′(R(t1))R′(t1)]
= c′(t1)[g(t1)− p(R(t1))] + c(t1)[g′(t1)− p′(R(t1)) · 0]
= c′(t1)[g(t1)− p(R(t1))] + c(t1)g′(t1).
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At t1, R
′(t1) = 0 which implies that c(t1)[g(t1)− p(R(t1))] = 0. Since c(t) > 0,
g(t1)− p(R(t1)) = 0. This gives us
R′′(t1) = c(t1)g′(t1)
< 0 since c(t1) > 0 and g
′(t1) < 0.
This is a contradiction to the previous result (3.1.4) that R′′(t) ≥ 0.
This result implies that there is only one T where R(t) is maximum. When
R(t) increases to maximum, it stays in the region A3 afterwards where R(t) is
strictly decreasing and never returns to A1 or A2. The next proof shows that
lim
t→∞
R(t) = 0.
VI Claim: lim
t→∞
R(t) = 0
Proof. Suppose not, then lim
t→∞
R(t) = α where α > 0. Note that R(t) is always
positive so α cannot go below zero.
Since R(t) is decreasing, R(t) ≥ α whenever t > T . By hypothesis, p(R(t)) is
a strictly increasing function, thus
p(R(t)) ≥ p(α)
or −p(R(t)) ≤ −p(α)
which implies that g(t)− p(R(t)) ≤ g(t)− p(α)
and c(t)[g(t)− p(R(t))] ≤ c(t)[g(t)− p(α)]
and so R′(t) ≤ c(t)[g(t)− p(α)]
Now, since g(t) → 0 as t → ∞, there exist a time t1 > T , where g(t) < 12p(α)
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for all t > t1. This then implies that
R′(t) < c(t)
[
1
2
p(α)− p(α)
]
R′(t) < −1
2
c(t)p(α).
From the hypothesis, c(t) is bounded below by b1, hence
R′(t) < −1
2
b1p(α).
For any t > t1, by the mean value theorem, there exists τ ∈ (t1, t) such that
R′(τ) =
R(t)−R(t1)
t− t1 .
Since τ is a time after t1
R(t)−R(t1)
t− t1 < −
1
2
b1p(α)
R(t) < R(t1)− 1
2
b1p(α)(t− t1).
Note that R(t1) is ﬁnite but as t gets large t− t1 → ∞. So there is some t after
T where R(t) < 0.
This is a contradiction to our earlier result that R(t) ≥ 0.
Hence, lim
t→∞
R(t) = 0.
This concludes the proof of theorem P.
3.2 Application of the Peak Theorem
In this section, we apply theorem P to the PK/PD models discussed in chapter 2, to
understand more about their time to peak.
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3.2.1 Peak Theorem and Theis Models
We rewrite each of the models to obtain the form of the model used by the theorem.
1. For RM-1 in (2.1.1) we have the form
dR(t)
dt
= k
[a
k
f(t)−R(t)
]
In the notation used in theorem P,
c(t) = k,
g(t) =
a
k
f(t)
and p(R(t)) = R(t).
For the discrete case of RM-1, g(t) = 0 for t < 1 and g(t) = a
k
for t ≥ 1, which
doesn’t satisfy the properties of g(t) in theorem P, hence, the theorem cannot
be applied.
Nonetheless, it has a single peak at T = 1. Notice that for t < 1, R(t) is
increasing (2.1.7) and its maximum at t = 1 and for t ≥ 1, R(t) is decreasing
and its also maximum at t = 1.
The continuous case of RM-1 has
c(t) = k,
g(t) =
a
k(1 + t)
and p(R(t)) = R(t).
Note that c(t) = k which is a constant so it is continuous and bounded. More
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so, g(t) is a positive function and diminishing since
g′(t) = − a
b(1 + t)2
< 0
and lim
t→∞
g(t) = 0.
For p(R(t)), note that p(0) = R(0) = 0 and since R(t) is linear, it’s a strictly
increasing continuous function and there exist a time t where R(t) ≥ g(0).
Hence, by application, the solution of the continuous case of RM-1 by Theis has
only one peak.
2. From (2.1.19), RM-2 can be written as
dR(t)
dt
= k
[
a
k(1 + t)2
−R(t)
]
For this model, c(t) and p(R(t)) are same as RM-1 so the hypothesis of the
theorem is satisﬁed. Next, we have
g(t) =
a
k(1 + t)2
.
It’s easy to see that g(t) > 0 and lim
t→∞
g(t) = 0. Now,
g′(t) = − 2a
k(1 + t)3
< 0
and so g(t) is diminishing. As from RM-1, R(t) is linear there is a time where
R(t) ≥ g(0) = a
k
. Therefore, the second model by Theis also has a unique time
to peak.
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3. The equation for RM-3, (2.1.30), can written as
dR(t)
dt
= (f(t) + k)
[
af(t)
f(t) + k
−R(t)
]
.
For f(t) = 1
1+t
, we see that
c(t) =
1
1 + t
+ k
and for 0 < t < ∞, c(t) is bounded below by k when t = ∞ and above by k+1
when t = 0; i.e.
k < c(t) < k + 1
with k > 0 which satisﬁes the properties of c(t) in theorem P.
Now,
g(t) =
af(t)
f(t) + k
=
a
1 + k(1 + t)
.
We see that g(t) > 0 for a > 0 and lim
t→∞
g(t) = 0. We also have
g′(t) = − ak
(kt+ k + 1)2
< 0.
In conclusion, RM-3 also satisﬁes the hypothesis of theorem P, hence the solution
has a unique maximum and diminishes to zero.
3.3 Peak Theorem and Turnover Models
In this section we apply the Peak Theorem to the turnover models also discussed in
chapter 2.
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1. The inhibiting model TM-1 stated in (2.2.4) can be rewritten as
dR(t)
dt
= k[φ(t,D)−R(t)]
with parameter D > 0 and k > 0. Here,
c(t) = k
which is bounded and p(R(t)) = R(t)
which is same in Theis’ models discussed in the previous section. For TM-1,
g(t) = φ(t,D) =
De−t
1 +De−t
deﬁned in (2.2.3) and g(0) =
D
1 +D
.
For the limit, lim
t→∞
g(t) = lim
t→∞
D
et+D
= 0. We also have that
g′(t) = − De
t
(D + et)2
< 0 for all t.
Hence, TM-1 satisﬁes the hypothesis of theorem P and so has one unique peak.
2. The second turnover model TM-2 (2.2.5) can be written as
dR(t)
dt
= (1− αφ(t,D))
[
φ(t,D)
1− αφ(t,D) −R(t)
]
.
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In this case
c(t) = k(1− αφ(t,D))
and g(t) =
φ(t,D)
1− αφ(t,D) .
Since c′(t) =
Det
(D + et)2
> 0,
c(t) is strictly increasing so as t → ∞, c(t) is bounded above by k, i.e. limt→∞ c(t) =
k(1 − α · 0) = k. For t = 0, c(0) = k(1 − α D
1+D
) and so it’s bounded below by
k
(
1− αD
1+D
)
.
Note that 0 < α < 1 and 0 < D
1+D
< 1 and so 1− αD
1+D
< 1. Thus, we’ve shown
that c(t) is bounded i.e.
0 < k
(
1− αD
1 +D
)
< c(t) < k.
For g(t) =
φ(t,D)
1− αφ(t,D) =
D
et + (1− α)D,
and since 0 < α < 1, g(t) > 0 for all t ≥ 0.
Note that g(0) = D
1+(1−α)D > 0. Also, since e
t → ∞ as t → ∞, g(t) → 0 as
t → ∞. We also diﬀerentiate g(t) and we get
g′(t) = − De
t
(D(1− α) + et)2 < 0.
Thus g(t) satisﬁes required conditions of theorem P. We see that p(R(t)) = R(t)
is linear so there exists a t where R(t) ≥ g(0), since g(0) < ∞. Hence, theorem
P can be applied to TM-2.
3. Since TM-3 is equivalent to TM-1, theorem P also applies to TM-3.
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4. The last turnover model, TM-4, (2.2.7) can also be written as
dR(t)
dt
= k(1 + αφ(t,D))
(
φ(t,D)
1 + αφ(t,D)
−R(t)
)
.
In this case c(t) = k(1 + αφ(t,D))
which is bounded below by k when t = ∞ and bounded above by k + αkD
1+D
.
Hence, properties of c(t) are satisﬁed for theorem P.
Also,
g(t) =
φ(t,D)
1 + αφ(t,D)
=
D
et + αD +D
> 0
for t ∈ [0,∞). We also have that g(0) = D
1+D+αD
which is positive and bounded.
Diﬀerentiating g(t), we get
g′(t) = − De
t
(et + αD +D)2
< 0.
In conclusion, theorem P can be applied.
The solution of these models are always positive, each has one peak and the solution
goes to zero as time goes to inﬁnity.
In the next chapter, we investigate how the time to peak T , depends on the drug
dosage D.
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Chapter 4
Dependence of T on D
In this chapter we consider a more general equation than discussed in chapter 2 and
chapter 3. All solutions that satisfy the conditions of the Peak Theorem, have only
one T . In this chapter we investigate the dependence of T on the drug dosage D. We
determine integral conditions for which T increases as D increases or vice-versa.
We consider the linear initial value problem
dR(t,D)
dt
= f(t,D)− h(t,D)R(t,D) (4.0.1)
R(0, D) = 0 (4.0.2)
where h(t,D) and f(t,D) are positive quantities. This equation includes all the linear
PK/PD models discussed in previous chapters.
We write the solution of this ﬁrst order linear diﬀerential equation in an integral form.
Using the integrating factor
μ(t,D) = e
∫ t
0 h(τ,D)dτ , (4.0.3)
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we ﬁnd that
dR(t,D)
dt
μ(t,D)− h(t,D)R(t,D)μ(t,D) = μ(t,D)f(t,D) (4.0.4)
d
dt
(R(t,D)μ(t,D)) = μ(t,D)f(t,D). (4.0.5)
Now, integrating both sides,
R(τ,D)μ(τ,D)
∣∣∣t
0
=
∫ t
0
μ(τ,D)f(τ,D)dτ (4.0.6)
R(t,D)μ(t,D) = R(0, D) +
∫ t
0
μ(τ,D)f(τ,D)dτ (4.0.7)
R(t,D) =
1
μ(t,D)
(∫ t
0
μ(τ,D)f(τ,D)dτ
)
(4.0.8)
4.1 The General Model and the Peak Theorem
Rewriting (4.0.1) in the form of theorem P,
dR(t,D)
dt
= h(t,D)
[
f(t,D)
h(t,D)
−R(t,D)
]
. (4.1.1)
To satisfy the condition of theorem P, we take
c(t) = h(t,D)
and require h(t,D) to be bounded i.e. 0 < b1 < h(t,D) < b2 where b1, b2 ∈ (0,∞)
We take
g(t) =
f(t,D)
h(t,D)
.
We require f(t,D)
h(t,D)
> 0 at all times and f(0,D)
h(0,D)
< ∞ since g(0) is bounded above. By so
doing, we get that R(t) > f(0,D)
h(0,D)
at some R.
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Theorem P requires that g′(t) < 0, which requires
(
f(t,D)
h(t,D)
)′
< 0. Since
d
dt
(
f(t,D)
h(t,D)
)
=
h(t,D)f ′(t,D)− f(t,D)h′(t,D)
h2(t,D)
(4.1.2)
we require h(t,D)f ′(t,D)− f(t,D)h′(t,D) < 0. (4.1.3)
If both f(t,D) and h(t,D) are positive, we have the condition that
f ′(t,D)
f(t,D)
− h
′(t,D)
h(t,D)
< 0. (4.1.4)
4.2 Time to Peak T and its Derivative TD
If the maximum response Rmax, occurs at t = T then
dR
dt
= 0 and from (4.0.1) we get
−h(T,D)R(T,D) + f(T,D) = 0. (4.2.1)
It is worth noting that T is a function of the dosage D, that is T = T (D). From
(4.2.1), f , h and R are given functions hence they’re known quantities and T is de-
ﬁned implicitly by this equation.
Our goal is to determine how T changes as D changes. We take partial derivatives of
(4.2.1) to obtain a relationship for TD
−R(T,D)(hT (T,D)TD + hD(T,D))− h(T,D)(RT (T,D)TD +RD(T,D))
+fT (T,D)TD + fD(T,D) = 0 (4.2.2)
where the subscripts T and D represent partial derivatives.
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Dropping all the (T,D) for convenience, we have that
−R · hT · TD −R · hD − h ·RT · TD − h ·RD + fT · TD + fD = 0 (4.2.3)
TD(fT −R · hT − h ·RT ) = (R · hD + h ·RD − fD). (4.2.4)
Now, (4.0.8) gives us a general solution for R(t,D). We take partial derivative of R
with respect to D
RD = −μD
μ2
(∫ T
0
(μ · f)dτ
)
+
1
μ
(∫ T
0
(μ · fD + f · μD)dτ
)
(4.2.5)
which then gives
RD = −μD
μ
R +
1
μ
(∫ T
0
(μ · fD + f · μD)dτ
)
. (4.2.6)
From (4.0.3), μD = μ
∫ t
0
hDdτ , substituting this result into equation (4.2.6),
RD = −R
∫ T
0
hDdτ +
1
μ
∫ T
0
(
μ · fD + μ · f
∫ τ
0
hDds
)
dτ (4.2.7)
= −R
∫ T
0
hDdτ +
1
μ
∫ T
0
μ
(
fD + f
∫ τ
0
hDds
)
dτ. (4.2.8)
Substituting RD in (4.2.8) into (4.2.4) we get
TD(fT −R · hT − h ·RT ) = R · hD − fD − h
[
R
∫ T
0
hDdτ − 1
μ
∫ T
0
μ
(
fD + f
∫ τ
0
hDds
)
dτ
]
(4.2.9)
Now
RT =
∂ R(T,D)
∂T
=
∂
∂T
[
1
μ(T,D)
(∫ T
0
μ(τ,D)f(τ,D)dτ
)]
.
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So
RT =
1
μ(T,D)
(∫ T
0
μ(τ,D)f(τ,D)dτ
)′
+
(
1
μ(T,D)
)′(∫ T
0
μ(τ,D)f(τ,D)dτ
)
where the ′ denotes partial diﬀerentiation with respect to T. So we have
(∫ T
0
μ(τ,D)f(τ,D)dτ
)′
= μ(T,D)f(T,D).
Also,
(
1
μ(T,D)
)′
= −h(T,D)R(T,D) + f(T,D). (4.2.10)
Substituting (4.2.10) into (4.2.9), we have
TD(fT −R · hT − h · (−h ·R + f))
= R · hD − fD − h
[
R
∫ T
0
hDdτ − 1
μ
∫ T
0
μ
(
fD + f
∫ τ
0
hDds
)
dτ
]
(4.2.11)
The R in (4.2.11) is the solution when the reaction is at a maximum, hence, from
(4.2.1)
R(T,D) =
f(T,D)
h(T,D)
.
Making this substitution in (4.2.11) gives us
TD
(
fT − f · hT
h
)
= f · hD
h
− fD − f
∫ T
0
hDdτ +
h
μ
∫ T
0
μ
(
fD + f
∫ τ
0
hDds
)
dτ.
(4.2.12)
From this we investigate if T is increasing or decreasing with respect to D by com-
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paring the signs of the two expressions LHE - Left-Hand Expression,
f
(
fT
f
− hT
h
)
(4.2.13)
and RHE - Right-Hand Expression
f
(
hD
h
− fD
f
)
− f
∫ T
0
hDdτ +
h
μ
∫ T
0
μ
(
fD + f
∫ τ
0
hDds
)
dτ. (4.2.14)
We do so by using the properties of the functions involved i.e. f , h at T , which help
make useful conclusions about the time to peak T .
4.3 Investigating the Sign of TD
Since f > 0 and from (4.1.4) fT
f
− hT
h
< 0,
f
(
fT
f
− hT
h
)
< 0
and the sign of LHE is always negative.
To investigate the sign of the RHE, we will use the turnover models to help compare
the terms in the RHE.
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4.3.1 RHE for Turnover TM-1 and TM-3
Recall that
f(t,D) = k
D
et +D
and h = k.
Since hD = 0 =
∫ T
0
hDdτ,
we have RHE = −fD + k
μ
∫ T
0
μfDτ. (4.3.1)
Since,
fD =
keT
(eT +D)2
(4.3.2)
and μ = e
∫ T
0 hdτ = ekT (4.3.3)
we have RHE =
−keT
(eT +D)2
+
k
ekT
∫ T
0
k
eτ(k+1)
(eτ +D)2
dτ. (4.3.4)
Multiplying by e
kT
k
we get
ekT
k
RHE = − e
T (k+1)
(eT +D)2
+ k
∫ T
0
eτ(k+1)
(eτ +D)2
dτ. (4.3.5)
ekT
k
RHE = − e
Tk
eT +D
· e
T
eT +D
+ k
∫ T
0
eτ(k+1)
(eτ +D)2
dτ. (4.3.6)
From (4.2.1),
f(T,D) = h(T,D)R(T,D)
and from (4.0.8)
R(T,D) =
1
μ(T,D)
(∫ T
0
μ(τ,D)f(τ,D)dτ
)
.
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Substituting R(T,D) into f(T,D), we have
f(T,D) =
h(T,D)
μ(T,D)
(∫ T
0
μ(τ,D)f(τ,D)dτ
)
. (4.3.7)
This implies that
D
eT +D
=
k
ekT
∫ T
0
Dekτ
eτ +D
dτ (4.3.8)
DekT
eT +D
=
∫ T
0
kDekτ
eτ +D
dτ. (4.3.9)
Now, substituting (4.3.9) into (4.3.6), we have
ekT
k
RHE =
eT
D(eT +D)
· −
∫ T
0
kDekτ
eτ +D
dτ + k
∫ T
0
eτ(k+1)
(eτ +D)2
dτ. (4.3.10)
=
∫ T
0
[
keτ(k+1)
(eτ +D)2
− ke
T ekτ
(eT +D)(eτ +D)
]
dτ (4.3.11)
= k
∫ T
0
ekτ
(eτ +D)
[
eτ
eτ +D
− e
T
eT +D
]
dτ. (4.3.12)
Note that e
τ
eτ+D
is an increasing function, i.e.
d
dτ
(
eτ
eτ +D
)
=
Deτ
(eτ +D)2
> 0 (4.3.13)
This shows that e
kT
k
RHE < 0 and RHE< 0. So the sign of TD is positive (TD > 0)
hence, the time to peak is increases as dosage D increases.
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4.3.2 RHE for TM-2
Before considering this case we make some general modiﬁcation by substituting (4.3.7)
into the ﬁrst term of RHE (4.3.4). So we have,
f
(
hD
h
− fD
f
)
=
h
μ
(
hD
h
− fD
f
)∫ T
0
μfdτ
=
h(T,D)
μ(T,D)
∫ T
0
[
μ(τ,D)f(τ,D)
(
hD(T,D)
h(T,D)
− fD(T,D)
f(T,D)
)]
dτ.
(4.3.14)
For the second term in RHE (4.3.4) we have,
−f
∫ T
0
hDdτ = −
(
h
μ
∫ T
0
μfdτ
)
·
∫ T
0
hDdτ
=
h(T,D)
μ(T,D)
∫ T
0
[
μ(τ,D)f(τ,D)
(
−
∫ T
0
hD(s,D)ds
)]
dτ (4.3.15)
Substituting (4.3.14) and (4.3.15) into RHE (4.3.4), we have
RHE =
h(T,D)
μ(T,D)
∫ T
0
[
μ(τ,D)f(τ,D)
(
hD(T,D)
h(T,D)
− fD(T,D)
f(T,D)
)
+μ(τ,D)f(τ,D)
(
−
∫ T
0
hD(τ,D)dτ
)
+μ(τ,D)fD(τ,D) + μ(τ,D)f(τ,D)
∫ τ
0
hD(s,D)ds
]
dτ
(4.3.16)
which then becomes
RHE =
h(T,D)
μ(T,D)
∫ T
0
μ(τ,D)f(τ,D)
[(
hD(T,D)
h(T,D)
− fD(T,D)
f(T,D)
)
+
fD(τ,D)
f(τ,D)
+
∫ τ
0
hD(s,D)ds−
∫ T
0
hD(s,D)ds
]
dτ.
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and simpliﬁes to
RHE =
h(T,D)
μ(T,D)
∫ T
0
μ(τ,D)f(τ,D)
[(
fD(τ,D)
f(τ,D)
− fD(T,D)
f(T,D)
)
+
hD(T,D)
h(T,D)
−
∫ T
τ
hD(s,D)ds
]
dτ. (4.3.17)
For TM-2,
f = k
D
et +D
and h = k
(
1− α D
et +D
)
.
Then,
fD(τ,D)
f(τ,D)
− fD(T,D)
f(T,D)
=
1
D
(
eτ
eτ +D
− e
T
eT +D
)
(4.3.18)
and
hD(T,D)
h(T,D)
= − αe
T
(eT +D)(eT +D(1− α)) .
Also,
∫ T
τ
hD(s,D)ds =
∫ T
τ
− αke
s
(es +D)2
ds
= −αk
∫ eT+D
eτ+D
du
u2
= αk
(
1
eT +D
− 1
eτ +D
)
Note that the sign of hD(T,D)
h(T,D)
is negative.
The remaining terms are,
fD(τ,D)
f(τ,D)
− fD(T,D)
f(T,D)
−
∫ T
τ
hD(s,D)ds =
1
D
[eτ (eT +D)− eT (eτ +D)]− αk(eτ − eT )
(eT +D)(eτ +D)
=
(eτ − eT )(1− αk)
(eT +D)(eτ +D)
.
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For 1−αk > 0 or k < 1
α
, RHE< 0 and hence TD is positive. In conclusion, T increases
as D increases whenever k < 1
α
.
4.3.3 RHE for TM-4
For TM-4,
f = k
D
et +D
and h = k
(
1 + α
D
et +D
)
.
Since f is same as that for TM-1 to TM-3, from 4.3.17 and 4.3.18 we have
fD(τ,D)
f(τ,D)
− fD(T,D)
f(T,D)
=
eτ − eT
(eτ +D)(eT +D)
< 0
Also,
hD(T,D)
h(T,D)
=
αeT
(eT +D)(eT +D(1 + α))
> 0
and
∫ T
τ
hD(s,D)ds =
∫ T
τ
αkes
(es +D)2
ds
= αk
(
1
eτ +D
− 1
eT +D
)
=
αk(eT − eτ )
(eτ +D)(eT +D)
> 0
Now
fD(τ,D)
f(τ,D)
− fD(T,D)
f(T,D)
+
hD(T,D)
h(T,D)
−
∫ T
τ
hD(s,D)ds
=
1
eT +D
[
eτ − eT
eτ +D
+
αeT
eT +D(1 + α)
− αk(e
T − eτ )
eτ +D
]
=
(−1− αk)(eT − eτ )(eT +D(1 + α)) + αeT (eτ +D)
(eT +D)(eτ +D)(eT +D(1− α))
(4.3.19)
So if −1 − αk > 0 or 1 + αk < 0, then RHE is positive, which will imply that T is
decreasing as D increases. However, this assertion for T is false since 1+αk is strictly
positive.
46
Chapter 5
Discussion, Conclusion and Future
Work
We begun by reviewing some of the models by Theis et al. (2011), Nguyen et al.
(2009), Sharma and Jusko (1996), Dayneka et al. (1993) and others; giving some
details of the models. We explained the models by giving the biological reasons for
the terms involved. The reaction models, RM-1 to RM-6, from Theis et al. (2011),
started with a simple PK/PD (ﬁrst order linear diﬀerential equation) and increased
the complexity by including additional parameters and constraints to describe ob-
served dynamics in biological responses and data. We showed that there are several
common features of the turnover models, TM-1 to TM-4 which produce responses by
indirect mechanisms. The reaction models and turnover models helped our analysis
and discussions in this paper.
In chapter 3, we proved Peak Theorem (theorem P), which addresses the question of
whether a maximum response occurs after a drug is administered. The theorem con-
siders a general non-linear diﬀerential equation, of the form dr(t)
dt
= c(t)[g(t) − p(r)].
We proved that if c(t) is a positive, continuous and bounded function, g(t) is a pos-
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itive, continuous and diminishing function, and p(r) is strictly increasing continuous
function where p(r) > g(0) at some t, then the solution r is deﬁned, bounded, has a
unique maximum at time T and diminishes to zero as t → ∞. We applied theorem
P to RM-1 to RM-3, and TM-1 to TM-4 and showed that each model satisﬁed the
conditions of theorem P and thus has a single time to peak.
The existence of a single time to peak (theorem P) led the analysis of chapter 4 where
we investigated how the time to peak depends on drug dosage. We used a general
linear diﬀerential equation (4.0.1) together with its general integral solution to derive
an expression for TD (changes in T with respect to changes in the drug dosage D)
(4.2.12). We found two expressions, LHE and RHE depending only on f and h, which
show that T increases withD when LHE and RHE have the same signs and vice-versa.
This result led us to ﬁnd some information on how T varies with D for the turnover
models. First, we used the analysis in chapter 4 to show that the sign of LHE is
negative under the conditions of the Peak theorem. For TM-1 and TM-3, we showed
that T increases when D increases. For TM-2, we showed that for k < 1
α
, T increases
as D increases. However, Nguyen et al. (2009) showed that for k > 1
α
and α < 1
2
, T
increases with D. There still remain the range k > 1
α
where α > 1
2
to be investigated.
For future work, we can investigate TM-4 further by using a numerical approach to
determine how T changes with D. This would beneﬁt from clinical trial data to es-
timate values of α, k and D. We can also investigate and obtain conditions for the
terms in RHE which will guarantee that T increases or decreases as D changes. We
can also analyze the general nonlinear model (3.1.1) to investigate how T changes
with D using a similar approach for the linear version in chapter 4.
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As mentioned earlier, the analysis in this paper focuses on administration of drugs
into the system of an organism, however, it is valid for any application governed by
a ﬁrst order ordinary diﬀerential equation with diminishing forcing and other mild
restriction on the form of the feedback.
In conclusion, this thesis has many applications for many regulated feedback networks.
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Appendix - Matlab Codes
RM-1 Discrete Version
---------------------
a = 1;
k = 1;
t1 = linspace(0,1)’;
t2 = linspace(1,3)’;
X = [t1,t2];
Y = [a/k*(1-exp(-k*t1)),a/k*(exp(-k*(t2-1))-exp(-k*t2))];
figure
stairs(X,Y)
xlabel(’t’) % x-axis label
ylabel(’R(t)’) % y-axis label
RM-1 Continuous Version
-----------------------
a = 1;
k = 1;
t = linspace(0,1)’;
Y = (a*exp(-k*(t+1))).*(-expint(-k*t-k)+expint(-k));
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RM-2
----
a = 1;
k = 1;
t = linspace(0,1);
Y = a*(exp(-k*t)-(1./(1+t))+k*exp(-k*(1+t)).*(-expint(-k*t-k)+expint(-k)));
RM-3
----
a = 1;
k = 1;
t = linspace(0,20);
Y = a*(1-exp(-k*t))./(k*(1+t));
TM-1 and TM-3
-------------
d = 1;
k = 1;
Pe = @(tau,d,k) d*exp(-tau)./(1+d*exp(-tau)).*exp(k*tau);
Y = zeros(1001,1);
i=1;
for t=0:0.01:10
Y(i) = k*exp(-k*t)*integral(@(tau) Pe(tau,d,k),0,t);
i=i+1;
end
t = linspace(0,10,1001);
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figure
plot(t,Y)
xlabel(’t’)
ylabel(’R(t)’)
TM-2
----
d = 1;
k = 1;
a = 0.5;
P = @(tau,d) d*exp(-tau)./(1+d*exp(-tau));
Q = @(s,d) d*exp(-s)./(1+d*exp(-s));
Y = zeros(1001,1);
i=1;
for t=0:0.01:10
Y(i) = k*exp(-k*t+a*k.*integral(@(tau)P(tau,d),0,t))
.*integral(@(tau) P(tau,d).*exp(k*tau-a*k
.*integral(@(s)Q(s,d),0,0.01)),0,t);
i=i+1;
end
t = linspace(0,10,1001);
figure
plot(t,Y)
xlabel(’t’)
ylabel(’R(t)’)
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TM-4
-----
d = 1;
k = 1;
a = 0.5;
P = @(tau,d) d*exp(-tau)./(1+d*exp(-tau));
Q = @(s,d) d*exp(-s)./(1+d*exp(-s));
Y = zeros(1001,1);
i=1;
for t=0:0.01:10
Y(i) = k*exp(-k*t-a*k.*integral(@(tau)P(tau,d),0,t))
.*integral(@(tau) P(tau,d).*exp(k*tau+a*k
.*integral(@(s)Q(s,d),0,0.01)),0,t);
i=i+1;
end
t = linspace(0,10,1001);
figure
plot(t,Y)
xlabel(’t’)
ylabel(’R(t)’)
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